Guardant Health, Inc.
GHNASDAQHealthcareDiagnostics & Research
As of Oct 26, 2026 close
- Market cap
- $23.02B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $66.59$191.05
- Volume (live)
- -
- Avg. volume (3M)
- 1.90M
Guardant Health (GH) Stock Price & Financial Analysis
Guardant Health Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $168.73 - $175.08 |
|---|---|
| 52-Week High | $191.05 |
| 52-Week Low | $66.59 |
| Open | $170.10 |
| Volume (last close) | 2.00M |
| Average Volume (3M) | 1.90M |
| Revenue (TTM) | 1.18B |
|---|---|
| Net Income (TTM) | -453.44M |
| Free Cash Flow (TTM) | -240.72M |
| EPS (TTM) | −$3.50 |
| Profit Margin | -38.33% |
| Operating Margin | -39.75% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 23.02B |
|---|---|
| Shares Outstanding | 132.87M |
| Price to Sales (P/S) | 19.46 |
| Price to Book (P/B) | -103.29 |
| EV/EBITDA | -52.59 |
| 50-Day MA | $167.78 |
|---|---|
| 200-Day MA | $127.84 |
| 1-Year Change | +134.95% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Guardant Health at a Glance
As of the Oct 26, 2026 close, Guardant Health (GH) has a market capitalization of $23.02B. The stock trades at 19.5× sales. Over the trailing twelve months it lost $453.44M on revenue of $1.18B and burned $240.72M of free cash flow. Revenue grew 42.7% year over year.
As of its latest reported balance sheet, it holds $1.05B in cash and securities against $1.53B of debt, a net debt position of $477.23M.
Guardant Health does not currently pay a dividend.
The share price is up 135.0% over the past year. At $173.25 (the Oct 26, 2026 close) it sits near the top of its 52-week range of $66.59 to $191.05, above its 200-day moving average of $127.84.
Based on 23 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $199.00, 14.9% above the Oct 26, 2026 close.
Frequently Asked Questions About Guardant Health
What is the current stock price for GH?
As of the Oct 26, 2026 close, GH stock trades at $173.25. The 52-week range is $66.59–$191.05, with a day range of $168.73–$175.08.
What is the P/E ratio for GH?
The P/E ratio (Price-to-Earnings) for GH is shown in the Key Statistics section. This valuation metric helps compare Guardant Health, Inc. to industry peers.
Does GH pay dividends?
Guardant Health does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GH?
Based on ratings from 23 professional analysts over the last 90 days, the consensus for GH is Buy. The average 12-month price target is $199.00, a 14.9% upside from the Oct 26, 2026 close of $173.25.
What is the market cap of GH?
As of the Oct 26, 2026 close, Guardant Health's market capitalization is $23.02B, classifying it as a large-cap company. Guardant Health operates in the Healthcare sector within the Diagnostics & Research industry.